1. Home
  2. PMTS vs MCRB Comparison

PMTS vs MCRB Comparison

Compare PMTS & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPI Card Group Inc.

PMTS

CPI Card Group Inc.

N/A

Current Price

$16.05

Market Cap

152.4M

Sector

Finance

ML Signal

N/A

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

N/A

Current Price

$8.93

Market Cap

139.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PMTS
MCRB
Founded
2007
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.4M
139.7M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
PMTS
MCRB
Price
$16.05
$8.93
Analyst Decision
Strong Buy
Hold
Analyst Count
3
3
Target Price
$27.67
$14.33
AVG Volume (30 Days)
81.5K
88.7K
Earning Date
06-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
100.00
EPS
1.25
2.40
Revenue
$312,189,000.00
$126,325,000.00
Revenue This Year
$9.09
N/A
Revenue Next Year
$6.79
N/A
P/E Ratio
$12.56
$3.73
Revenue Growth
12.27
1672.24
52 Week Low
$10.81
$0.36
52 Week High
$30.51
$29.98

Technical Indicators

Market Signals
Indicator
PMTS
MCRB
Relative Strength Index (RSI) 64.36 36.34
Support Level $13.84 $6.99
Resistance Level $16.38 $16.14
Average True Range (ATR) 1.01 0.53
MACD 0.48 0.24
Stochastic Oscillator 67.45 53.87

Price Performance

Historical Comparison
PMTS
MCRB

About PMTS CPI Card Group Inc.

CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: